BusinessWorld Online
Philippines will have enough vaccines for adults, palace says
The Philippine government aims to secure enough vaccines for 70 million Filipinos by the end of 2021, despite delays in the first Pfizer-BioNTech shipment from COVAX.
The first batch of 117,000 Pfizer-BioNTech vaccines from COVAX was delayed due to the absence of an indemnification measure for adverse side effects.
The Philippines plans to acquire over 160 million vaccine doses from multiple suppliers, including WHO's COVAX facility, Sinovac, Gamaleya, Novavax, AstraZeneca, Moderna, Pfizer-BioNTech, and Johnson & Johnson.
Most of the vaccines will be administered in two doses, except for Johnson & Johnson's single-shot vaccine.
Presidential spokesperson Harry Roque emphasized that the country's vaccine strategy is not limited to Western vaccines, with Novavax expected to provide the largest volume of doses.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippine government is on track to secure 170 million doses of COVID-19 vaccines to inoculate between 50 to 70 million Filipinos this year.
Read more →
The Philippines is expecting 600,000 doses of the Sinovac COVID-19 vaccine to arrive on February 23.
Read more →
The Philippines is aiming to complete its COVID-19 vaccination program by 2023, with a possibility of achieving good outcomes by 2022.
Read more →
The Philippines will not lose its 44 million vaccine allocation from the COVAX facility despite a one-week delay in the delivery of Pfizer vaccines.
Read more →
Manufacturing complications and the absence of an indemnification agreement have caused delays in the delivery of AstraZeneca COVID-19 vaccines to the Philippines.
Read more →